Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Miralbell

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Anticancer Research|December 17, 1998
Combined chemoradiotherapy for invasive bladder cancer: a feasibility approach in a non selected populationC de Pree, M S Aapro, B Mermillod, et al.
International Journal of Cancer|December 18, 2001
Invasive bladder carcinoma: a pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatinA Zouhair, M Ozsahin, D Schneider, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1997
Combined concomitant boost radiotherapy and chemotherapy in stage III-IV head and neck carcinomas: a comparison of toxicity and treatment results with those observed after radiotherapy aloneA S Allal, S Bieri, R Miralbell, et al.
Bone Marrow Transplantation|June 1, 1993
Conditioning the leukemic patient before allogeneic BMT: value of intensifying immunosuppression in the context of different levels of T lymphocyte depletion of the graftR Miralbell, B Chapuis, P Nouet, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1993
Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparisonA Allal, J M Kurtz, G Pipard, et al.
Nuklearmedizin. Nuclear Medicine|July 28, 2015
Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patientsO Rager, A Baskin, G Amzalag, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1990
Fibromatoses: from postsurgical surveillance to combined surgery and radiation therapyR Miralbell, H D Suit, H J Mankin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 23, 2009
Estimated dose to the rectum and colon in prostate cancer patients treated with exclusive radiation therapy presenting a secondary colorectal malignancyD C Weber, H Wang, C Bouchardy, et al.
Journal of Neuro-Oncology|April 25, 2000
Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel densityR Miralbell, M Tolnay, S Bieri, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 20, 2009
Characteristics and outcome of prostate cancer with PSA <4 ng/ml at diagnosis: a population-based studyM Bonet, A Merglen, G Fioretta, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Anticancer Research|December 17, 1998
Combined chemoradiotherapy for invasive bladder cancer: a feasibility approach in a non selected populationC de Pree, M S Aapro, B Mermillod, et al.
International Journal of Cancer|December 18, 2001
Invasive bladder carcinoma: a pilot study of conservative treatment with accelerated radiotherapy and concomitant cisplatinA Zouhair, M Ozsahin, D Schneider, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1997
Combined concomitant boost radiotherapy and chemotherapy in stage III-IV head and neck carcinomas: a comparison of toxicity and treatment results with those observed after radiotherapy aloneA S Allal, S Bieri, R Miralbell, et al.
Bone Marrow Transplantation|June 1, 1993
Conditioning the leukemic patient before allogeneic BMT: value of intensifying immunosuppression in the context of different levels of T lymphocyte depletion of the graftR Miralbell, B Chapuis, P Nouet, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 1993
Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparisonA Allal, J M Kurtz, G Pipard, et al.
Nuklearmedizin. Nuclear Medicine|July 28, 2015
Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patientsO Rager, A Baskin, G Amzalag, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 1990
Fibromatoses: from postsurgical surveillance to combined surgery and radiation therapyR Miralbell, H D Suit, H J Mankin, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|June 23, 2009
Estimated dose to the rectum and colon in prostate cancer patients treated with exclusive radiation therapy presenting a secondary colorectal malignancyD C Weber, H Wang, C Bouchardy, et al.
Journal of Neuro-Oncology|April 25, 2000
Pediatric medulloblastoma: prognostic value of p53, bcl-2, Mib-1, and microvessel densityR Miralbell, M Tolnay, S Bieri, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 20, 2009
Characteristics and outcome of prostate cancer with PSA <4 ng/ml at diagnosis: a population-based studyM Bonet, A Merglen, G Fioretta, et al.
Pageof 7